BioSpace News Archive

LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, will showcase a unique new triculture system during the Society of Toxicology Annual Meeting and ToxExpo in San Diego, March 27-31.

Prothena Corporation plc announced that members of its senior management team will participate in a fireside chat at the Stifel 2022 Virtual CNS Days on Monday March 28, 2022 at 12:30 PM ET.

Terns Pharmaceuticals, Inc. reported top-line results from Part 1 of the Company’s Phase 1b AVIATION Trial of TERN-201, a vascular adhesion protein-1 inhibitor in development for the treatment of patients with NASH.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, announced the appointment of Dr. Randall Kaye as Chief Medical Officer.

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the fourth quarter and full year ended December 31, 2021.

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company focused on the development and commercialization of adeno-associated virus -based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, announced that it has commenced an underwritten public offering of its common stock.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Stifel 2022 CNS Days virtual conference at 3:30 p.m. Eastern Time on Monday, March 28, 2022.

Augmedix, Inc., a leading provider of automated medical documentation and data services, reported financial results for the three months ended December 31, 2021.

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced the appointment of Ms. Ruth Alon to its Board of Directors, effective immediately.

Pulse Biosciences, Inc. announced today it will report financial results for the fourth quarter and full year of 2021 after market close on Thursday, March 31, 2022.